What are the main side effects of filzonetam?

Fezolinetant is a selective neurokinin 3 (NK3) receptor antagonist, primarily used to treat menopausal-related vasomotor symptoms (VMS), such as hot flashes and night sweats. Its mechanism of action is different from traditional hormone replacement therapy (HRT). It reduces the occurrence of hot flashes by regulating the temperature regulation center of the hypothalamus, thus providing a new option for women who are not suitable or unwilling to use estrogen treatment. Although Fezonatant is relatively safe, it may still cause a series of side effects involving the liver, gastrointestinal tract, nervous system, metabolism and other aspects.

1. Abnormal liver function

One of the most concerning side effects of filazonatant is abnormal liver function. Clinical trials have shown that some patients may experience an increase in liver enzymes (ALT, AST) after using this drug. Although in most cases the increase is mild and asymptomatic, in a few cases it may lead to more serious liver damage. Therefore, liver function should be monitored regularly during the use of fezonatant, especially in patients with a history of liver disease. If significant abnormalities in liver function occur (such as significant elevations in ALT or AST), the dose may need to be adjusted or the medication discontinued.

2. Gastrointestinal adverse reactions

Fezonatant may cause gastrointestinal symptoms such as nausea, abdominal pain, diarrhea, or constipation. These adverse effects are usually mild and resolve over time. However, in patients with gastrointestinal sensitivities, additional supportive care may be needed, such as dietary modification, increased fluid intake, or symptomatic medications.

3. Nervous system-related side effects

Some patients may experience headache, dizziness, fatigue, or insomnia after taking felazonatant. Among them, headache and dizziness are the more common discomfort symptoms, which may be related to the regulatory effect of drugs on the central nervous system. In most cases, these symptoms are mild and do not interfere with daily activities, but if symptoms are severe or persistent, dosage adjustments or other treatment options may be needed. In addition, fezonatant may affect the sleep quality of some patients, causing insomnia or easy waking at night, which may be related to its role in regulating neurotransmitters.

4. Metabolic and endocrine effects

Although Fezonastat is not a hormonal drug, it may still affect hormone balance in the body. Some patients may experience weight changes (gain or loss), changes in appetite, or mild edema after taking this medication. These changes usually do not affect the overall effectiveness of the drug, but in patients sensitive to weight management, additional attention to diet and exercise may be needed.

5. Vascular-related adverse reactions

Although fezonatant is used to relieve hot flashes during menopause, in rare cases, patients may experience worsening hot flashes, flushed skin, or blood pressure fluctuations. There is currently no conclusive evidence that filazonatant significantly increases the risk of cardiovascular events, but since menopausal women themselves are at high risk for cardiovascular disease, they still need to pay attention to blood pressure and cardiovascular health during treatment.

6. Other rare side effects

In addition to the common side effects listed above, filazonatant may cause mild discomfort such as dry mouth, joint pain, or muscle pain. The incidence of these symptoms is low and usually does not interfere with continued use of the medication. If the patient experiences severe or persistent discomfort while taking the medication, it is recommended to consult a physician to evaluate whether the treatment regimen needs to be adjusted.

In general, as a non-hormonal NK3 receptor antagonist, fizonitant has relatively fewer side effects than traditional hormone replacement therapy (HRT) and does not increase the risk of breast cancer or thrombotic events. However, it may still cause liver function abnormalities, gastrointestinal discomfort, neurological symptoms, metabolic changes, and vascular-related adverse reactions. Therefore, during use of this drug, it is recommended to regularly monitor liver function, pay attention to possible symptoms of discomfort, and adjust the treatment plan if necessary. For patients with severe liver disease, cardiovascular disease, or other chronic diseases, a physician should be consulted before use to ensure a safe and effective treatment plan.

Reference materials:https://www.veozah.com/